Search

Your search keyword '"Schöni-Affolter F"' showing total 33 results

Search Constraints

Start Over You searched for: Author "Schöni-Affolter F" Remove constraint Author: "Schöni-Affolter F" Database OAIster Remove constraint Database: OAIster
33 results on '"Schöni-Affolter F"'

Search Results

1. Trends in mortality in people with HIV from 1999 to 2020: a multi-cohort collaboration

2. Population pharmacokinetic analysis of elvitegravir and cobicistat in HIV-1-infected individuals

3. Assessing efficacy of different nucleos(t)ide backbones in NNRTI-containing regimens in the Swiss HIV Cohort Study

4. The Interplay Between Host Genetic Variation, Viral Replication, and Microbial Translocation in Untreated HIV-Infected Individuals

5. Assessing the Paradox Between Transmitted and Acquired HIV Type 1 Drug Resistance Mutations in the Swiss HIV Cohort Study From 1998 to 2012

6. Clustering of HCV coinfections on HIV phylogeny indicates domestic and sexual transmission of HCV

7. Treatment-Naive Individuals Are the Major Source of Transmitted HIV-1 Drug Resistance in Men Who Have Sex With Men in the Swiss HIV Cohort Study

8. Hepatitis B Virus Infection Is Associated With Impaired Immunological Recovery During Antiretroviral Therapy in the Swiss HIV Cohort Study

9. Higher Risk of Incident Hepatitis C Virus Coinfection Among Men Who Have Sex With Men, in Whom the HIV Genetic Bottleneck at Transmission Was Wide

10. Improved darunavir genotypic mutation score predicting treatment response for patients infected with HIRaben-1 subtype B and non-subtype B receiving a salvage regimen

11. Improved darunavir genotypic mutation score predicting treatment response for patients infected with HIRaben-1 subtype B and non-subtype B receiving a salvage regimen

12. Improved darunavir genotypic mutation score predicting treatment response for patients infected with HIRaben-1 subtype B and non-subtype B receiving a salvage regimen

13. Improved darunavir genotypic mutation score predicting treatment response for patients infected with HIRaben-1 subtype B and non-subtype B receiving a salvage regimen

14. Incident Hepatitis C Virus Infections in the Swiss HIV Cohort Study : changes in treatment uptake and outcomes between 1991 and 2013

15. Increases in condomless sex in the Swiss HIV Cohort Study.

16. Strong impact of smoking on multimorbidity and cardiovascular risk among human immunodeficiency virus-infected individuals in comparison with the general population.

17. Obesity trends and body mass index changes after starting antiretroviral treatment : the Swiss HIV Cohort Study

18. Non-AIDS defining cancers in the D:A:D Study - time trends and predictors of survival: A cohort study

19. Minor protease inhibitor mutations at baseline do not increase the risk for a virological failure in HIV-1 subtype B infected patients.

20. Tuberculosis in HIV-negative and HIV-infected patients in a low-incidence country: clinical characteristics and treatment outcomes.

21. Diagnostic performance of line-immunoassay based algorithms for incident HIV-1 infection

22. Hepatitis E Virus seroprevalence and chronic infections in patients with HIV, Switzerland

23. High specificity of line-immunoassay based algorithms for recent HIV-1 infection independent of viral subtype and stage of disease

24. Estimating loss to follow-up in HIV-infected patients on antiretroviral therapy: The effect of the competing risk of death in Zambia and Switzerland

25. Population pharmacokinetic analysis of elvitegravir and cobicistat in HIV-1-infected individuals

26. Assessing efficacy of different nucleos(t)ide backbones in NNRTI-containing regimens in the Swiss HIV Cohort Study

27. The Interplay Between Host Genetic Variation, Viral Replication, and Microbial Translocation in Untreated HIV-Infected Individuals

28. Assessing the Paradox Between Transmitted and Acquired HIV Type 1 Drug Resistance Mutations in the Swiss HIV Cohort Study From 1998 to 2012

29. Clustering of HCV coinfections on HIV phylogeny indicates domestic and sexual transmission of HCV

30. Origin of Minority Drug-Resistant HIV-1 Variants in Primary HIV-1 Infection

31. Treatment-Naive Individuals Are the Major Source of Transmitted HIV-1 Drug Resistance in Men Who Have Sex With Men in the Swiss HIV Cohort Study

32. Hepatitis B Virus Infection Is Associated With Impaired Immunological Recovery During Antiretroviral Therapy in the Swiss HIV Cohort Study

33. Higher Risk of Incident Hepatitis C Virus Coinfection Among Men Who Have Sex With Men, in Whom the HIV Genetic Bottleneck at Transmission Was Wide

Catalog

Books, media, physical & digital resources